{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:41:02Z","timestamp":1791168062847,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9,24]]},"DOI":"10.1097\/qad.0b013e32836378c3","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T13:05:15Z","timestamp":1370351115000},"page":"2425-2430","source":"Crossref","is-referenced-by-count":41,"title":["Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia"],"prefix":"10.1097","volume":"27","author":[{"given":"Lambert","family":"Assoumou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Katlama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Viard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Bentata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Kolta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Rozenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210130","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","article-title":"Diagnosis of osteoporosis and assessment of fracture risk.","volume":"359","author":"Kanis","year":"2002","journal-title":"Lancet"},{"key":"R2-10-20210130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/QAD.0b013e3280148c05","article-title":"Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.","volume":"21","author":"Arnsten","year":"2007","journal-title":"AIDS"},{"key":"R3-10-20210130","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"R4-10-20210130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1359\/JBMR.0301246","article-title":"BMD is reduced in HIV-infected men irrespective of treatment.","volume":"19","author":"Amiel","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R5-10-20210130","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1097\/QAD.0b013e328340a28d","article-title":"High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study.","volume":"24","author":"Bonjoch","year":"2010","journal-title":"AIDS"},{"key":"R6-10-20210130","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","article-title":"Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.","volume":"17","author":"Bruera","year":"2003","journal-title":"AIDS"},{"key":"R7-10-20210130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e3282f423dd","article-title":"Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.","volume":"22","author":"Cazanave","year":"2008","journal-title":"AIDS"},{"key":"R8-10-20210130","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS"},{"key":"R9-10-20210130","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.bone.2011.01.015","article-title":"Prospective one-year bone loss in treatment-naive HIV men and women on single or multiple drug HIV therapies.","volume":"48","author":"Briot","year":"2011","journal-title":"Bone"},{"key":"R10-10-20210130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/QAD.0b013e328328f789","article-title":"Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.","volume":"23","author":"Duvivier","year":"2009","journal-title":"AIDS"},{"key":"R11-10-20210130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"R12-10-20210130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1468-1293.2007.00525.x","article-title":"Evolution of bone mineral density in AIDS patients on treatment with zidovudinelamivudiine plus abacavir or lopinavirritonavir.","volume":"9","author":"Rivas","year":"2008","journal-title":"HIV Med"},{"key":"R13-10-20210130","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/QAD.0b013e32832c4947","article-title":"First line zidovudinelamivudinelopinavirritonavir leads to greater bone loss compared to nevirapinelopinavirritonavir.","volume":"23","author":"van Vonderen","year":"2009","journal-title":"AIDS"},{"key":"R14-10-20210130","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/infdis\/jir188","article-title":"Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224 s, a substudy of ACTG A5202.","volume":"203","author":"McComsey","year":"2011","journal-title":"J Infect Dis"},{"key":"R15-10-20210130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2265.2007.02875.x","article-title":"Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.","volume":"67","author":"Bolland","year":"2007","journal-title":"Clin Endocrinol"},{"key":"R16-10-20210130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/367569","article-title":"Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.","volume":"36","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R17-10-20210130","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00002030-200107060-00009","article-title":"Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir.","volume":"15","author":"Nolan","year":"2001","journal-title":"AIDS"},{"key":"R18-10-20210130","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jocd.2012.04.001","article-title":"Prevalence of low bone mineral density in men and women infected with human immunodeficiency virus 1 and a proposal for screening strategy.","volume":"15","author":"Mary-Krause","year":"2012","journal-title":"J Clin Densitom"},{"key":"R19-10-20210130","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1089\/aid.2011.0224","article-title":"Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).","volume":"28","author":"Rozenberg","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R20-10-20210130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s001980070070","article-title":"Follow-up of individual patients on two DXA scanners of the same manufacturer.","volume":"11","author":"Kolta","year":"2000","journal-title":"Osteoporos Int"},{"key":"R21-10-20210130","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1359\/jbmr.1999.14.8.1449","article-title":"Individual smallest detectable difference in bone mineral density measurements.","volume":"14","author":"Ravaud","year":"1999","journal-title":"J Bone Miner Res"},{"key":"R22-10-20210130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1385\/JCD:1:3:279","article-title":"Bone densitometry: choosing the proper skeletal site to measure.","volume":"1","author":"Faulkner","year":"1998","journal-title":"J Clin Densitom"},{"key":"R23-10-20210130","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/jbmr.5650091002","article-title":"Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results.","volume":"9","author":"Genant","year":"1994","journal-title":"J Bone Miner Res"},{"key":"R24-10-20210130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jclinepi.2009.12.008","article-title":"Missing covariate data in medical research: to impute is better than to ignore.","volume":"63","author":"Janssen","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"R25-10-20210130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R","article-title":"Multiple imputation of missing blood pressure covariates in survival analysis.","volume":"18","author":"Van Buuren","year":"1999","journal-title":"Stat Med"},{"key":"R28-10-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QCO.0b013e328334fe9a","article-title":"HIV and bone mineral density.","volume":"23","author":"Mallon","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"R29-10-20210130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/656417","article-title":"Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.","volume":"51","author":"Stellbrink","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R31-10-20210130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/aid.2011.0052","article-title":"Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir.","volume":"28","author":"Masia","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R32-10-20210130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s001980200001","article-title":"Changes in bone mineral density with age in men and women: a longitudinal study.","volume":"13","author":"Warming","year":"2002","journal-title":"Osteoporos Int"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e32836378c3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:36:15Z","timestamp":1620970575000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201309240-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,24]]},"references-count":29,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32836378c3","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,24]]}}}